Dr. Reddy's Laboratories, operating in the Pharmaceuticals sector and classified as a Largecap on the bse, currently has its share price at 1391.35 The stock has experienced fluctuations today, with a low of ₹1346.9 and a high of ₹1398.7 Over the past 52 weeks, the shares have seen a low of ₹1104.69 and a high of ₹1420.2.
In terms of performance, Dr. Reddy's Laboratories has shown a return of 2.67% in one day, 15.9% over the past month, and 2.99% in the last three months.
Analyzing the technicals, the daily pivot level for the stock is set at 1378.98. The resistance levels are identified as R1 at 1411.07, R2 at 1430.78, and R3 at 1462.87. On the support side, the levels are marked as S1 at 1359.27, S2 at 1327.18, and S3 at 1307.47.
In the realm of technical analysis for our subject stock, the moving averages present a detailed picture. Over a short span of 5 days, the Simple Moving Average (SMA) stands at 1246.56, while the Exponential Moving Average (EMA) is noted at 1353.99. Extending the view to a 10-day period, the SMA adjusts to 1233.75 with the EMA slightly differing at 1325.
In a comparative analysis of stock performance within its sector, Dr. Reddy's Laboratories stands alongside several key competitors, each showcasing varied performance metrics over different time periods. Dr. Reddy's Laboratories itself has recorded performance figures of 1W % is 3.64 over the past week, 16.66% in the last month, and 2.94% over the past three months. Its six-month, one-year, three-year, and five-year performances are 6 month % is 8.6, 1yr % is 18.96, 3Y % is 46.66, and 5Y % is 140.63 respectively.
Read More
R1 | 1,411.07 | |
R2 | 1,430.78 | |
R3 | 1,462.87 | |
Pivot 1,378.98 | ||
S1 | 1,359.27 | |
S2 | 1,327.18 | |
S3 | 1,307.47 |
Day | SMA | EMA |
---|---|---|
5 | 1,246.56 | 1,353.99 |
10 | 1,233.75 | 1,325 |
20 | 1,221.8 | 1,294.34 |
50 | 1,274.35 | 1,282.39 |
100 | 1,317.99 | 1,286.58 |
200 | 1,275.88 | 1,264.94 |
Name | 1W% | 1M% | 3M% | 6M% | 1Y% | 3Y% | 5Y% |
---|---|---|---|---|---|---|---|
3.64 | 16.66 | 2.94 | 8.60 | 18.96 | 46.66 | 140.63 | |
2.94 | 7.29 | -3.35 | 22.29 | 47.52 | 128.43 | 333.05 | |
0.67 | -1.17 | 8.04 | 28.05 | 49.39 | 30.04 | 218.29 | |
2.30 | 0.90 | -8.93 | 1.75 | 19.51 | 61.38 | 213.95 | |
2.49 | 12.07 | 13.95 | 34.99 | 44.04 | 101.76 | 101.76 | |
-0.85 | 6.28 | 0.15 | 22.05 | 50.81 | 116.73 | 266.99 | |
3.73 | 11.44 | 1.71 | 37.41 | 66.33 | 143.00 | 189.49 | |
-0.15 | 2.54 | -8.98 | -9.48 | 41.72 | 112.28 | 280.61 | |
2.28 | 2.57 | -13.14 | 5.08 | 16.49 | 75.00 | 172.73 | |
1.39 | 0.91 | -9.13 | 10.34 | 7.44 | 58.06 | 176.83 | |
2.49 | 7.23 | 0.66 | 6.21 | 29.75 | 54.03 | 122.49 | |
2.86 | 6.11 | -5.21 | 28.91 | 85.27 | 209.15 | 358.83 | |
4.84 | -3.19 | -2.99 | 0.34 | 42.39 | -1.01 | 20.68 | |
3.46 | 8.37 | 9.51 | 44.51 | 49.42 | 57.43 | 188.39 | |
-0.59 | -5.81 | -17.56 | -14.38 | 22.85 | 29.95 | 40.89 | |
6.58 | 3.78 | -4.99 | 32.94 | 52.55 | 101.39 | 373.90 | |
0.73 | 3.60 | 11.14 | 61.97 | 84.12 | 35.87 | 35.87 | |
4.86 | 6.34 | 26.72 | 38.22 | 37.44 | 10.83 | 715.01 | |
2.44 | 5.52 | 0.99 | -0.63 | -6.27 | -53.23 | -0.41 | |
-1.33 | -8.61 | -0.70 | 44.96 | 67.18 | 138.98 | 593.54 |
Fund Name | No. Of Shares | % of AUM | Amount Invested (in ₹ crore) |
---|---|---|---|
SBI Nifty 50 ETF | 1,12,36,556 | 0.68 | 1,350.97 |
Parag Parikh Flexi Cap Fund | 69,65,116 | 0.99 | 837.42 |
ICICI Prudential Value Discovery Fund | 57,48,252 | 1.41 | 691.11 |
Nippon India Large Cap Fund | 47,67,429 | 1.62 | 573.19 |
HDFC Flexi Cap Fund - Regular Plan | 40,79,518 | 0.74 | 490.48 |
Nippon India Pharma Fund | 36,62,170 | 5.1 | 440.3 |
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund | 35,58,630 | 8.48 | 427.85 |
UTI Nifty 50 ETF | 33,58,919 | 0.68 | 403.84 |
ICICI Prudential Bluechip Fund | 28,74,805 | 0.54 | 345.64 |
Tata Equity P/E Fund - Regular Plan | 22,05,000 | 3.07 | 265.11 |
Price | (%) As on Invalid Date | IST |
Open Interest | (%) |
High | |
Low | |
Open | |
Close | |
Contract Traded | |
Turnover (in lakhs) |
Dr. Reddy's Labs - Announcement under Regulation 30 (LODR)-Credit Rating This is to inform that ICRA Limited has reaffirmed the credit rating assigned to the bank facility of the Company as per attached letter. 27-Dec, 2024 | 06:06 PM |
Dr. Reddy's Labs - Announcement under Regulation 30 (LODR)-Acquisition Incorporation of step down wholly-owned subsidiary 23-Dec, 2024 | 07:52 PM |
Dr. Reddy's Labs - Board Meeting Intimation for Board Meeting Intimation For Approval Of Unaudited Financial Results Of The C DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2025 ,inter alia, to consider and approve The Unaudited Financial Results of the Company for the quarter and nine months ending on December 31, 2024 23-Dec, 2024 | 07:00 PM |
Dr. Reddy's Labs - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 06-Dec, 2024 | 04:27 PM |
Dr. Reddy's Labs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Schedule of Analyst / Institutional Investor Meeting 03-Dec, 2024 | 03:32 PM |
Dr. Reddy's Laboratories Ltd. is a Public Limited Listed company incorporated on 24/02/1984 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L85195TG1984PLC004507 and registration number is 004507. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company’s Total Operating Revenue is Rs. 14405.20 Cr. and Equity Capital is Rs. 83.20 Cr. for the Year ended 31/03/2022.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Dr. Reddy's Laboratories is ₹1,391.35 as on Dec 27, 2024.
The Dr. Reddy's Laboratories is operating in the Pharmaceuticals Sector. It is classified as a Largecap stock on the BSE.
The market cap of Dr. Reddy's Laboratories is ₹116,097.58 Cr as on Dec 27, 2024.
Today’s highest and lowest price of Dr. Reddy's Laboratories are ₹1,398.70 and ₹1,346.90.
The 52-week high/low is the highest and lowest price at which Dr. Reddy's Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Dr. Reddy's Laboratories is ₹1,420.20 and 52-week low of Dr. Reddy's Laboratories is ₹1,104.69 as on Dec 27, 2024.
The Dr. Reddy's Laboratories has shown returns of 2.67% over the past day, 15.9% for the past month, 2.99% over 3 months, 21.77% over 1 year, 46.9% across 3 years, and 140.33% over 5 years.
P/E ratio of and PB ratio of Dr. Reddy's Laboratories are 21.75 and 4.11 on Dec 27, 2024. While the company gives a dividend yield of 0.57 per annum.